This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • BOTOX� in the Treatment of Urinary Incontinence Du...
Clinical trial

BOTOX� in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 8 to 17 Years of Age

Read time: 1 mins
Last updated:25th Apr 2013
The objective of this study is to evaluate the safety and efficacy of BOTOX for the treatment of urinary incontinence due to Neurogenic Detrusor Overactivity (NDO) in patients 8 to 17 years of age who have not been adequately managed with anticholinergic therapy.
Category Value
Study start date 2013-04-25

View full details